Long-Term Debt: The sum of all long term debt fields.
Neumora Therapeutics, Inc. (NMRA) had Long-Term Debt of $19.45M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-52.73M |
|
-- |
|
-- |
|
$54.04M |
|
$-54.04M |
|
$1.33M |
|
$-52.71M |
|
$-52.71M |
|
$-52.73M |
|
$-52.73M |
|
$-52.73M |
|
$-52.73M |
|
$-54.04M |
|
$-54.92M |
|
161.69M |
|
161.69M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$222.91M |
|
$0.09M |
|
$0.92M |
|
$223.82M |
|
$21.16M |
|
|
Long-Term Debt |
$19.45M |
$19.79M |
|
$40.95M |
|
$182.88M |
|
$182.88M |
|
$182.88M |
|
161.95M |
|
| Cash Flow Statement Financials | |
$-111.85M |
|
$74.56M |
|
$18.46M |
|
$143.36M |
|
$124.52M |
|
$-18.84M |
|
$16.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.54 |
|
-- |
|
-- |
|
0.10 |
|
0.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-111.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.83% |
|
-28.83% |
|
-23.56% |
|
-26.06% |
|
$1.13 |
|
$-0.69 |
|
$-0.69 |
|